GLENMARK PHARMACEUTICALS EUROPE LTD — Montelukast Importer Profile
Pharmaceutical Importer · #15 buyer for Montelukast · $1.2M import value · 73 shipments · UNITED KINGDOM · DGFT Verified
GLENMARK PHARMACEUTICALS EUROPE LTD is the #15 importer of Montelukast from India with $1.2M in import value and 73 verified shipments. GLENMARK PHARMACEUTICALS EUROPE LTD holds a 0.7% market share in Montelukast imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, GLENMARK PHARMACEUTICALS EUROPE LTD imports 3 pharmaceutical products worth $1.6M across 3 therapeutic categories.
GLENMARK PHARMACEUTICALS EUROPE LTD — Montelukast Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Montelukast to GLENMARK PHARMACEUTICALS EUROPE LTD?
Verified from 73 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | $1.2M | 73 | 100.0% |
GLENMARK PHARMACEUTICALS EUROPE LTD sources Montelukast from 1 verified Indian supplier based on 73 customs records. The primary supplier is GLENMARK PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does GLENMARK PHARMACEUTICALS EUROPE LTD Compare to Nearest Montelukast Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | UNICHEM PHARMACEUTICALS (USA) INC | UNITED STATES | $1.4M | 29 | $50.0K |
| 14 | ACCORD UK | UNITED KINGDOM | $1.3M | 45 | $28.8K |
| 15 | GLENMARK PHARMACEUTICALS EUROPE LTD ★ | UNITED KINGDOM | $1.2M | 70 | $17.7K |
| 17 | ORION CORPORATION | FINLAND | $966.3K | 45 | $21.5K |
| 11 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $750.0K | 15 | $50.0K |
GLENMARK PHARMACEUTICALS EUROPE LTD ranks #15 among 1,324 Montelukast importers from India. Average shipment value of $17.7K compared to the market average of $23.1K. The closest competitors by value are UNICHEM PHARMACEUTICALS (USA) INC and ACCORD UK.
Where Does GLENMARK PHARMACEUTICALS EUROPE LTD Import Montelukast To?
Destination countries from 73 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.2M | 73 | 100.0% |
GLENMARK PHARMACEUTICALS EUROPE LTD imports Montelukast to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $1.2M.
What Montelukast Formulations Does GLENMARK PHARMACEUTICALS EUROPE LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| MONTELUKAST 10MG FILMCOATED TAB 28S GPEL | $359.6K | 28 |
| Montelukast 10mg Filmcoated Tab 28s GPEL | $355.8K | 15 |
| PHARMACEUTICALS MONTELUKAST 10MG FILMCOATED TAB 28S GPEL | $120.3K | 5 |
| PHARMACEUTICALS : MONTELUKAST 10MG FILMCOATED TAB 28S GPEL | $60.0K | 3 |
| MONTELUKAST 10MG FILMCOATED TAB 28S GPELNOS | $58.3K | 4 |
| Montelukast 10mg Filmcoated Tab 28s GPEL(SUK0100081280901AS) Batch no.19241969A/19241990A / 19241992A/19242006A.,.. | $50.0K | 1 |
| PHARMACEUTICALS :MONTELUKAST 10MG FILMCOATED TAB 28S GPEL | $39.9K | 1 |
| MONTELUKAST 10MG FILMCOATED TAB 28S GPEL,B.NO.19240976A,19240978A,MFG:08-MAR-2024,EXP:28-FEB-2027 | $34.2K | 3 |
| MONTELUKAST 10MG FILMCOATED TAB 28S GPEL,B.NO.19240447A,19240464A,MFG:02-FEB-2024,03-FEB-2024,EXP:31-JAN-2027 | $32.3K | 1 |
| PHARMACEUTICALS :MONTELUKAST 5MG CHEWABLE TABLETS 28S UK | $21.9K | 2 |
GLENMARK PHARMACEUTICALS EUROPE LTD imports 17 distinct Montelukast formulations from India. The top formulation is MONTELUKAST 10MG FILMCOATED TAB 28S GPEL with 28 shipments worth $359.6K.
Regulatory Requirements: Importing Montelukast into United Kingdom
What GLENMARK PHARMACEUTICALS EUROPE LTD and other importers must comply with to import Montelukast from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Montelukast
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Montelukast from India and How Much Does GLENMARK PHARMACEUTICALS EUROPE LTD Import?
India exported $30.6M worth of Montelukast through 6,431 shipments from 510 suppliers to 138 countries, serving 1,324 buyers globally. GLENMARK PHARMACEUTICALS EUROPE LTD imports $1.2M of this total, accounting for 0.7% of India's Montelukast exports with 73 shipments from UNITED KINGDOM. This is verified from 73 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for GLENMARK PHARMACEUTICALS EUROPE LTD's Montelukast Imports?
GLENMARK PHARMACEUTICALS EUROPE LTD's average Montelukast order value is $16.9K per consignment, based on 73 shipments totaling $1.2M. GLENMARK PHARMACEUTICALS EUROPE LTD is based in UNITED KINGDOM and ranks #15 among all Montelukast importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Montelukast to GLENMARK PHARMACEUTICALS EUROPE LTD?
GLENMARK PHARMACEUTICALS EUROPE LTD sources Montelukast from 1 verified Indian supplier: GLENMARK PHARMACEUTICALS LIMITED ($1.2M, 100.0%). This is based on 73 customs records.
How Does GLENMARK PHARMACEUTICALS EUROPE LTD Compare to Other Montelukast Importers?
GLENMARK PHARMACEUTICALS EUROPE LTD ranks #15 among 1,324 Montelukast importers from India with a 0.7% market share. The top 3 importers are UNICHEM PHARMACEUTICALS (USA) INC. ($5.6M), BREATHEFREE LANKA PVT LTD ($3.4M), UNICHEM PHARMACEUTICALS USA INC ($2.6M). GLENMARK PHARMACEUTICALS EUROPE LTD processed 73 shipments from UNITED KINGDOM.
About GLENMARK PHARMACEUTICALS EUROPE LTD
GLENMARK PHARMACEUTICALS EUROPE LTD imports 3 products worth $1.6M. Beyond Montelukast, top products include Efavirenz, Emtricitabine. View the complete GLENMARK PHARMACEUTICALS EUROPE LTD profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Montelukast — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GLENMARK PHARMACEUTICALS EUROPE LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GLENMARK PHARMACEUTICALS EUROPE LTD's capped import value divided by total capped export value for Montelukast across all Indian exporters.
- 5.Verified Records: This page is backed by 73 individual customs records matching GLENMARK PHARMACEUTICALS EUROPE LTD importing Montelukast, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 1,324+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Montelukast Import Data for GLENMARK PHARMACEUTICALS EUROPE LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for GLENMARK PHARMACEUTICALS EUROPE LTD's Montelukast imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GLENMARK PHARMACEUTICALS EUROPE LTD
Full Company Profile →
3 products · $1.6M total trade · 3 categories
GLENMARK PHARMACEUTICALS EUROPE LTD × Montelukast
Verified from customs records
Company Overview
Top Products by GLENMARK PHARMACEUTICALS EUROPE LTD
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GLENMARK PHARMACEUTICALS EUROPE LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Montelukast. For current order-level data, contact TransData Nexus.